Ari VanderWalde
Impact in
- Oncology top 0.5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 2%
- Immunotherapy and Immune Responses
Papers in
- Oncology 35
- CAR-T cell therapy research 9
- Cancer Immunotherapy and Biomarkers 9
- Lung Cancer Research Studies 4
-
- Lung Cancer Treatments and Mutations 20
- Co-authors
- Zoran Gatalica (3 shared papers)David Spetzler (6 shared papers)Anthony J. Olszanski (5 shared papers)Nianqing Xiao (1 shared paper)John Lindsay Marshall (1 shared paper)John M. Kirkwood (4 shared papers)Georgina Venetia Long (4 shared papers)Igor J. Puzanov (4 shared papers)
- Journals
- Annals of Oncology (6 papers)Journal of Clinical Oncology (4 papers)The Lancet Oncology (3 papers)Clinical Lung Cancer (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Ari VanderWalde
77 papers receiving 6.1k citations
Ari VanderWalde's Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 3.8k
- Immunology 1.5k
- Genetics 1.9k
- Otorhinolaryngology 181
- Biotechnology 365
Countries citing papers authored by Ari VanderWalde
This map shows the geographic impact of Ari VanderWalde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ari VanderWalde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ari VanderWalde more than expected).
Fields of papers citing papers by Ari VanderWalde
This network shows the impact of papers produced by Ari VanderWalde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ari VanderWalde. The network helps show where Ari VanderWalde may publish in the future.
Co-authors
The 25 scholars most cited alongside Ari VanderWalde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma Hit paper breakdown → | 2015 | 2149 |
| 2 | Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy Hit paper breakdown → | 2017 | 1306 |
| 3 | Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study Hit paper breakdown → | 2019 | 445 |
| 4 | 2018 | 379 | |
| 5 | Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma Hit paper breakdown → | 2022 | 215 |
| 6 | 2019 | 184 | |
| 7 | 2018 | 144 | |
| 8 | 2015 | 139 | |
| 9 | 2015 | 134 | |
| 10 | 2023 | 129 | |
| 11 | 2020 | 85 | |
| 12 | 2011 | 64 | |
| 13 | 2019 | 52 | |
| 14 | 2018 | 50 | |
| 15 | 2017 | 36 | |
| 16 | 2012 | 36 | |
| 17 | 2017 | 32 | |
| 18 | 2018 | 31 | |
| 19 | 2021 | 30 | |
| 20 | 2011 | 29 |
About Ari VanderWalde
Ari VanderWalde is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Pathology and Forensic Medicine and Immunology, having authored 88 papers that have together received 6.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (20 papers), Cancer Genomics and Diagnostics (14 papers), CAR-T cell therapy research (9 papers), Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (7 papers), Virus-based gene therapy research (7 papers), Genetic factors in colorectal cancer (6 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Oncology (3.8k citations), Immunology (1.5k citations), Genetics (1.9k citations), Otorhinolaryngology (181 citations) and Biotechnology (365 citations). Ari VanderWalde has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Zoran Gatalica, David Spetzler, Anthony J. Olszanski, Nianqing Xiao, John Lindsay Marshall, John M. Kirkwood, Georgina Venetia Long, Igor J. Puzanov, Josep Malvehy and Olivier Alain Michielin. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, The Lancet Oncology, Clinical Lung Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.